Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) shares were down 5.9% on Thursday . The company traded as low as $183.95 and last traded at $192.00. 244 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 2,401 shares. The stock had previously closed at $204.00.
Sartorius Stedim Biotech Price Performance
The company’s fifty day simple moving average is $199.42 and its 200 day simple moving average is $215.25.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell‐ and gene‐based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.
Key product offerings include single‐use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.
Read More
- Five stocks we like better than Sartorius Stedim Biotech
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Sartorius Stedim Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Stedim Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
